Applied Clinical Trials-11-01-2009

GLOBAL TRIALS : South Africa?s Positioning Fosters Healthy Trial Landscape Croatia?s Dynamic Qualities CROs Must Manage Italy?s Regulatory Makeover EDC?s Evolution in Japan Also in this issue : Postmarketing Pushes Back Approvals, EU Regulators Increase Involvement, Site Shake-Out Benefits Those That Remain, Is in Silico Modeling the Economic Solution?

Industry news focusing on the people and organizations who work in the clinical trials profession

As a part of Europe, but not the European Union, trials in Croatia can encounter special challenges

Implementing postmarketing strategies early on to avoid on-the-spot and costly requirements upon submission.

While it has yet to be fully integrated, electronic data capture is gaining ground in Japan.

Changing current business models with the use of new advancements for more sustainability.

Economic factors and sponsor practices will dramatically alter the investigative site landscape.

A rising initiative in Wales led by the International Business of Wales (IBW) promotes company growth in the region.

Economical development and regulatory standards make the country a logical choice for trials.

Health concerns require EU regulators to become more involved in the politics of health care.

FDA reviewers strive to assess new postmarketing programs while also evaluating applications.

How Italy's new quality-driven regulations will ask more of CROs conducting activities in the country.

A major European congress looks set to focus attention on the growing campaign for more participation of the elderly in clinical trials.